For Research Use Only Not for Human or Veterinary Use Description Additional information For In Vitro Research Use Only Not for Human or Veterinary Use Molecular Weight 711.9 Daltons Structure 5 AA Selective GHSR-1a Agonist Branded Packaging IDUN Custom labelled vial & box COA Per Lot 3rd Party Freedom Diagnostics, ships in box Identity LC-MS Mass-confirmed lot-by-lot Chemical & Physical Specifications About Ipamorelin Ipamorelin (H-Aib-His-D-2-Nal-D-Phe-Lys-NH) is a synthetic pentapeptide first reported by Raun and colleagues (1998) at Novo Nordisk A/S under the internal designation NNC 26-0161

Research suggests that berberine may: Improve insulin sensitivity Support healthy glucose metabolism Influence gut microbiota composition Enhance pathways involved in GLP-1 secretion Other ingredients that may support GLP-1 activity include: Prebiotic fibers like inulin Polyphenols from green tea Omega-3 fatty acids These nutrients work by supporting metabolic processes linked to increase GLP-1 naturally, rather than directly mimicking the hormone
Compounded medications are not FDA-approved, and their safety and effectiveness have not been independently verified by the FDA
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, McGowan BM, Rosenstock J, Tran MTD, Wadden TA, Wharton S, Yokote K, et al., for the STEP 1 Study Group
The severity and duration of these side effects vary considerably between individuals